Trials / Terminated
TerminatedNCT01076751
Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients
Observational Prospective Study of Survival, Treatment Patterns, Disease and Economic Outcomes in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Progression During or After a First-line Docetaxel-based Regimen
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Primary Objective: * Describe real-life survival of CRPC patients who received first-line docetaxel and have disease progression Secondary Objective: * Describe treatment patterns * Describe the characteristics and outcomes of patients who received second-line taxane-based treatment compared to others * Describe economic and patient-reported outcomes
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-02-26
- Last updated
- 2011-02-14
Locations
5 sites across 5 countries: United States, France, Germany, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01076751. Inclusion in this directory is not an endorsement.